Industry News
Checkpoint Inhibition Derails Head and Neck Cancer Progression
Researchers at the UCLA School of Dentistry have discovered a key molecule that allows...
Industry News
Genetic Changes That Inhibit Head and Neck Cancer Immunotherapy Identified
A multi-institutional team of researchers has identified both the genetic abnormalities that drive pre-cancer...
Industry News
Deactivation of Cancer Cell Gene Boosts Head and Neck Cancer Immunotherapy
By targeting an enzyme that plays a key role in head and neck cancer...
Industry News
Hydrogel Improves Oral Cancer Immunotherapy
Researchers from the University of Texas Health Science Center at Houston (UTHealth) and Rice...
Industry News
Immune Cells Can Be Trained to Target Cancer Tumors
Immunotherapies such as checkpoint inhibitor drugs have transformed cancer treatment. These drugs act on...
Industry News
Radiation and Immunotherapy Combination Shows Promise for HNSCC Treatment
A combination of radiation therapy and immunotherapy may lead to encouraging survival outcomes and...
Industry News
Preoperative Immunotherapy Triggers Encouraging Response in Oral Cancers
Immunotherapy given before other treatments for oral cavity cancers may elicit an immune response...
Industry News
DNA Vaccine Provokes Immune Responses in HPV-Related Head and Neck Cancer Cases
A therapeutic vaccine can boost antibodies and T cells, helping them infiltrate tumors and...
Industry News
MicroRNA Offers Clues in Identifying Aggressive Oral Cancer
About 8,000 Americans die of oral cancer each year, according to the Columbia University...